Journals / Turkish Thoracic Journal / 2021 / Cilt: 22 - Sayı: 5

Disseminated Tuberculosis: A 3-Year Case-Series Experience in a Tertiary Care Center

Pages
358–363
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Our data contribute to the current knowledge on the characteristics and outcomes of dTB patients in Turkey.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVE: Disseminated tuberculosis (dTB) is an important health issue resulting from the hematogenous spread of Mycobacterium tuberculosis, and is associated with a globally significant burden of morbidity and mortality.
📊
Key Findings & Data:MATERIAL AND METHODS: In the current case series, patients with dTB followed between 2017 and 2020 in our institution were retrospectively examined.
💡
Conclusion & Impact:Our data contribute to the current knowledge on the characteristics and outcomes of dTB patients in Turkey.
🔬Design:Research Article
📍Scope:2017 Verileri
⚙️Variables:Domain Parameters

Özet

OBJECTIVE: Disseminated tuberculosis (dTB) is an important health issue resulting from the hematogenous spread of Mycobacterium tuberculosis, and is associated with a globally significant burden of morbidity and mortality. Despite several studies from various countries, there are no data from Turkey specifically evaluating this special population. Our study aimed to evaluate the characteristics and treatment outcomes of dTB patients followed in our institution. MATERIAL AND METHODS: In the current case series, patients with dTB followed between 2017 and 2020 in our institution were retrospectively examined. Data regarding patient characteristics, diagnostic methods, organ involvement, radiological patterns, treatment regimen, and outcomes were recorded. Descriptive statistics were performed. RESULTS: In the present study, 23 dTB patients (median age 36, 56.5% male) were evaluated. The most common extrapulmonary manifestations were observed in the skeletal (n = 13) and genitourinary systems (n = 5). Multidrug-resistant TB was detected in 3 patients. The most common risk factors for dTB were living in a country with a high TB burden, and HIV infection. CONCLUSION: Foreign-born patients were at high risk for disseminated TB in our study. HIV infection was also defined as the most important risk factor. Our data contribute to the current knowledge on the characteristics and outcomes of dTB patients in Turkey.

🔖

Cite This Article

GÜNDÜZ, C., ŞEKERBEY, H., BABALIK, A. (2021). Disseminated Tuberculosis: A 3-Year Case-Series Experience in a Tertiary Care Center. Turkish Thoracic Journal, Cilt: 22 - Sayı: 5, 358–363. https://ajindex.com/articles/417904

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. World Health Organization. Global tuberculosis report. 2019 2. Tüberküloz Tanı ve Tedavi Rehberi, Sağlık Bakanlığı Yayın No 1129, 2019. 3. Daher Ede F, da Silva GB, Barros EJ. Renal tuberculosis in the modern era. Am J Trop Med Hyg. The American Society of Tropical Medicine and Hygiene. 2013
  2. 88(1):54-64. [CrossRef] 4. Gomes T, Reis-Santos B, Bertolde A, et al. Epidemiology of extrapulmonary tuberculosis in Brazil: a hierarchical model. BMC Infect Dis. 2014
  3. [CrossRef] 5. Peto HM, Pratt RH, Harrington TA, LoBue PA, Armstrong LR. Epidemiology of extrapulmonary tuberculosis in the United States, 1993-2006. Clin Infect Dis. 2009
  4. [CrossRef] 6. Khan FY. Review of literature on disseminated tuberculosis with emphasis on the focused diagnostic workup. J Family Community Med. 2019
  5. [CrossRef] 7. Meira L, Chaves C, Araújo D, et al. Predictors and outcomes of disseminated tuberculosis in an intermediate burden setting. Pulmonology. 2019
  6. [CrossRef] 8. Wang JY, Hsueh PR, Wang SK, et al. Disseminated tuberculosis: a 10-year experience in a medical center. Med (Baltim). 2007
  7. [CrossRef] 9. Tatar D, Senol G, Alptekin S, et al. Assessment of extrapulmonary tuberculosis in two provinces of Turkey. Iran J Public Health. 2016
  8. Sunnetcioglu M, Baran AI, Binici I, Esmer F, Gultepe B. Evaluation of 257 extra pulmonary tuberculosis cases at the tuberculosis Control Dispensary, Van, Turkey. J Pak Med Assoc. 2018
  9. World Health Organization (WHO). Strategic and Technical Advisory Group for TB (STAG-TB). Use of high burden country lists for TB by WHO in the post-2015 era. 2015. https://www. who.int/tb/publications/global_report/high_tb_burdencountrylists2016- 2020.pdf. Accessed March 15, 2020 12. Arpagaus A, Franzeck FC, Sikalengo G, et al. Extrapulmonary tuberculosis in HIV-infected patients in rural Tanzania: the prospective Kilombero and Ulanga antiretroviral cohort. PLOS ONE. 2020
  10. 15(3):e0229875. [CrossRef] 13. Lin JN, Lai CH, Chen YH, et al. Risk factors for extra-pulmonary tuberculosis compared to pulmonary tuberculosis. Int J Tuberc Lung Dis. 2009
  11. Rheum A, Dixon WG, Hyrich KL, et al. Extended report Drugspecific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR). Disorders. 2010
  12. Schutz C, Meintjes G, Almajid F, Wilkinson RJ, Pozniak A. Clinical manag